1. Novel Drug Therapeutics in Celiac Disease: A Pipeline Review

   • Sanskriti Varma
   • Suneeta Krishnareddy

   Leading Article 17 October 2022 Pages: 1515 - 1526

2. Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection

   • Sahil Khanna
   • Maha Assi
   • Paul Feuerstadt

   Original Research Article Open access 26 October 2022 Pages: 1527 - 1538

   

3. Publisher Correction: Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection

   • Sahil Khanna
   • Maha Assi
   • Paul Feuerstadt

   Correction Open access 07 November 2022 Pages: 1539 - 1539

4. Ripretinib: A Review in Gastrointestinal Stromal Tumours as Fourth-or Later-Line of Therapy

   • Simon Fung
   • Matt Shirley

   Adis Drug Evaluation 25 October 2022 Pages: 1541 - 1548

   

5. Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate: A Review in Symptomatic Uterine Fibroids

   • Yahiya Y. Syed

   Adis Drug Evaluation Open access 04 November 2022 Pages: 1549 - 1556

   

6. Pucotenlimab: First Approval

   • Sohita Dhillon

   AdisInsight Report 29 October 2022 Pages: 1557 - 1564